Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-07T21:52:19.366Z Has data issue: false hasContentIssue false

In vitro evaluation of a novel multiwalled carbon nanotube/nanohydroxyapatite/polycaprolactone composite for bone tissue engineering

Published online by Cambridge University Press:  21 February 2019

Huixiao Yang
Affiliation:
Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatological Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, People’s Republic of China
Jieqing Li
Affiliation:
Department of Breast Surgery, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin 300100, People’s Republic of China; and Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California 90059, USA
Qiong Liao
Affiliation:
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University) China, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, People’s Republic of China
Hua Guo
Affiliation:
Shriners Hospitals Pediatric Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA
Huishan Chen
Affiliation:
Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatological Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, People’s Republic of China
Yuting Zhu
Affiliation:
Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatological Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, People’s Republic of China
Meijuan Cai
Affiliation:
Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatological Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, People’s Republic of China
Huling Lv*
Affiliation:
Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatological Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510140, People’s Republic of China; and State Key Laboratory of Oral Diseases, Sichuan University West China College of Stomatology, Sichuan University, Chengdu, Sichuan 610041, People’s Republic of China
*
a)Address all correspondence to this author. e-mail: Jennifer6910@126.com

Abstract

In this study, a three-phased multiwalled scaffold, composed of carbon nanotube (mwCNT), nanocrystalline hydroxyapatite (nHA), and polycaprolactone (PCL), was fabricated by the solvent evaporation technique. The structure character, mechanical properties, and degradation activity in simulated body fluid (SBF), along with osteoproductive ability in human osteosarcoma cell MG63, were investigated thoroughly. Results showed that the three phases in mwCNT/nHA/PCL composite presented excellent miscibility and stronger interfacial force when the weight content was 1/15/84 (wt%). Simultaneously, the composite had smaller porosity and slower degradation rate, and there was massive crystallized hydroxyapatite formed on the surface after being soaked in SBF. With regard to bioactivity, MG63s on this scaffolds presented good proliferation performance and differentiated into the osteogenic lineage by expressing high levels of ALP. It was concluded that mwCNTs/nHA/PCL composite scaffolds might be beneficial for bone tissue engineering at a relatively low concentration of mwCNTs and nHA.

Information

Type
Article
Copyright
Copyright © Materials Research Society 2019 
Figure 0

Figure 1: SEM images of composite materials. (a) PCL only. (b) mwCNT/nHA/PCL. The mass fraction of mwCNT and nHA is 1% and 15%, respectively. (c) nHA/PCL with 15 wt% nHA. (d) nHA/PCL with 30 wt% nHA (e) mwCNT/PCL with 2 wt% mwCNT (black part is PCL matrix, lighter part is mwCNT or nHA).

Figure 1

Figure 2: XRD patterns of the composites (** represents the characteristic peaks of PCL; * indicates the peaks of nHA).

Figure 2

TABLE I: Compressive strength and tensile strength of composites.

Figure 3

Figure 3: (a) PH values, (b) weight loss, (c) the compressive strength of the composites immersed in SBF for 4 months. (Mean ± SD, n = 6). **indicates significant difference (P < 0.01) between groups connected by the underline, and ## means the significant difference (P < 0.01) between the group and the corresponding PCL group at each time point.

Figure 4

Figure 4: SEM images of the four scaffolds after being soaked in SBF solution for 16 weeks (a) PCL, (b) nHA/PCL, (c) mwCNT/PCL, and (d) mwCNT/nHA/PCL. Scale bar = 5 μm.

Figure 5

Figure 5: Images and quantification results of MG63 cultured for 1 day and 3 days under fluorescence microscope. (a, e) MG63s cultured on pure PCL. (b, f) MG63s cultured on mwCNTs/PCL scaffold. (c, g) MG63s cultured on nHA/PCL scaffold. (d, h) MG63s cultured on mwCNT/nHA/PCL scaffold. Scale bar is 100 µm.

Figure 6

Figure 6: (a) Cell proliferation ability and (b) ALP values of MG63 cells cultivated for 1, 3, 5, 7, and 9 days on four scaffolds (OD, Mean ± SD, n = 3).

Figure 7

Figure 7: Scheme for preparation of mwCNT/nHA/PCL composites.